Exact Sciences (EXAS) Cash from Financing Activities (2010 - 2025)

Exact Sciences (EXAS) has 16 years of Cash from Financing Activities data on file, last reported at -$75.9 million in Q4 2025.

• Cash from Financing Activities for Q4 2025 came in at -$75.9 million, down 822.67% year-over-year; the trailing twelve-month figure through Dec 2025 was -$338.1 million (down 245.81% YoY), and the FY2025 annual result was -$338.1 million, down 245.81% from the prior year.
• Cash from Financing Activities eased to -$75.9 million in Q4 2025 per EXAS's latest filing, from -$1.5 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $224.6 million in Q2 2024 and troughed at -$256.2 million in Q1 2025.
• A 5-year average of $6.9 million and a median of $1.5 million in 2022 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities jumped 4784.68% in 2023, then tumbled 8433.34% in 2025.
• A 5-year view of Cash from Financing Activities shows it stood at -$12.2 million in 2021, then soared by 182.84% to $10.1 million in 2022, then slipped by 0.65% to $10.0 million in 2023, then grew by 4.6% to $10.5 million in 2024, then plunged by 822.67% to -$75.9 million in 2025.
• Business Quant data shows EXAS's Cash from Financing Activities at -$75.9 million in Q4 2025, -$1.5 million in Q3 2025, and -$4.5 million in Q2 2025.